David Novack - Oct 1, 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
President & COO
Signature
/s/ David Novack
Stock symbol
DVAX
Transactions as of
Oct 1, 2021
Transactions value $
-$309,844
Form type
4
Date filed
10/5/2021, 07:04 PM
Previous filing
Sep 3, 2021
Next filing
Oct 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Sale -$310K -17K -20.22% $18.23 67.1K Oct 1, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $17.04 to $18.50; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.